Cargando…
Incidence and Distinct Features of Immune Checkpoint Inhibitor-Related Myositis From Idiopathic Inflammatory Myositis: A Single-Center Experience With Systematic Literature Review and Meta-Analysis
Immune checkpoint inhibitor (ICI)-related myositis is a rare, potentially fatal condition that warrants further studies. Its incidence, clinical features, and prognosis remain poorly understood. To address these gaps, we conducted a systematic review and meta-analysis to evaluate the risk of myositi...
Autores principales: | Hamada, Naoki, Maeda, Ayaka, Takase-Minegishi, Kaoru, Kirino, Yohei, Sugiyama, Yumiko, Namkoong, Ho, Horita, Nobuyuki, Yoshimi, Ryusuke, Nakajima, Hideaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686164/ https://www.ncbi.nlm.nih.gov/pubmed/34938300 http://dx.doi.org/10.3389/fimmu.2021.803410 |
Ejemplares similares
-
Incidence and Risk of Hematological Adverse Events Associated With Immune Checkpoint Inhibitors: A Systematic Literature Review and Meta-Analysis
por: Ohashi, Takuma, et al.
Publicado: (2023) -
Risk of Macrophage Activation Syndrome in Patients with Adult-Onset Still’s Disease Treated with IL-1 and IL-6 Inhibitors: A Meta-analysis and Single-Center Experience
por: Adachi, Soichiro, et al.
Publicado: (2023) -
Case Report: Tocilizumab Treatment for VEXAS Syndrome With Relapsing Polychondritis: A Single-Center, 1-Year Longitudinal Observational Study In Japan
por: Kunishita, Yosuke, et al.
Publicado: (2022) -
The Roles of Monocytes and Macrophages in Behçet’s Disease With Focus on M1 and M2 Polarization
por: Hirahara, Lisa, et al.
Publicado: (2022) -
Tropomyosin autoantibodies associated with checkpoint inhibitor myositis
por: Zaenker, Pauline, et al.
Publicado: (2020)